Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PROTEASE INHIBITOR THERAPY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 97 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Carrieri, P; Cailleton, V; Le Moing, V; Spire, B; Dellamonica, P; Bouvet, E; Raffi, F; Journot, V; Moatti, JP
      The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    2. Marimoutou, C; Chene, G; Mercie, P; Neau, D; Farbos, S; Morlat, P; Ceccaldi, J; Dabis, F
      Prognostic factors of combined viral load and CD4(+) cell count responses under triple antiretroviral therapy, aquitaine cohort, 1996-1998

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    3. Eron, JJ; Haubrich, R; Lang, W; Pagano, G; Millard, J; Wolfram, J; Snowden, W; Pedneault, L; Tisdale, M
      A phase II trial of dual protease inhibitor therapy: Amprenavir in combination with indinavir, nelfinavir, or saquinavir

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    4. Adje, C; Cheingsong, R; Roels, TH; Maurice, C; Djomand, G; Verbiest, W; Hertogs, K; Larder, B; Monga, B; Peeters, M; Eholie, S; Bissagene, E; Coulibaly, M; Respess, R; Wiktor, SZ; Chorba, T; Nkengasong, JN
      High prevalence of genotypic and phenotypic HIV-1 drug-resistant strains among patients receiving antiretroviral therapy in Abidjan, Cote d'Ivoire

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    5. Haubrich, R; Demeter, L
      Clinical utility of resistance testing: Retrospective and prospective datasupporting use and current recommendations

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    6. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    7. Mijch, AM; Hoy, J; Watson, K; Dunne, A; Crowe, S; Wesselingh, SL
      Does plasma HIV RNA predict outcome in a cohort of treated HIV-infected individuals followed over 3 years?

      JOURNAL OF CLINICAL VIROLOGY
    8. John, M; Nolan, D; Mallal, S
      Antiretroviral therapy and the lipodystrophy syndrome

      ANTIVIRAL THERAPY
    9. Walmsley, SL; Becker, MI; Zhang, M; Humar, A; Harrigan, PR
      Predictors of virological response in HIV-infected patients to salvage antiretroviral therapy that includes nelfinavir

      ANTIVIRAL THERAPY
    10. Lange, J
      A rational approach to the selection and sequencing of nucleoside/nucleotide analogues: a new paradigm

      ANTIVIRAL THERAPY
    11. Mallal, S
      Resistance and other factors involved in therapy failure

      ANTIVIRAL THERAPY
    12. Scully, C; Dios, PD
      Orofacial effects of antiretroviral therapies

      ORAL DISEASES
    13. Brook, MG; Dale, A; Tomlinson, D; Waterworth, C; Daniels, D; Forster, G
      Adherence to highly active antiretroviral therapy in the real world: experience of twelve English HIV units

      AIDS PATIENT CARE AND STDS
    14. Stone, VE
      Strategies for optimizing adherence to highly active antiretroviral therapy: Lessons from research and clinical practice

      CLINICAL INFECTIOUS DISEASES
    15. McNabb, J; Ross, JW; Abriola, K; Turley, C; Nightingale, CH; Nicolau, DP
      Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic

      CLINICAL INFECTIOUS DISEASES
    16. Kitchen, CM; Kitchen, SG; Dubin, JA; Gottlieb, MS
      Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome

      CLINICAL INFECTIOUS DISEASES
    17. Hanna, GJ; D'Aquila, RT
      Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy

      CLINICAL INFECTIOUS DISEASES
    18. Pradier, C; Carrieri, P; Bentz, L; Spire, B; Dellamonica, P; Moreau, J; Moatti, JP
      Impact of short-term adherence on virological and immunological success ofHAART: a case study among French HIV-infected IDUs

      INTERNATIONAL JOURNAL OF STD & AIDS
    19. Manfredi, R; Chiodo, F
      Limits of deep salvage antiretroviral therapy with nelfinavir plus either efavirenz or nevirapine, in highly pre-treated patients with HIV disease

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    20. Nunez, M; Rodriguez-Rosado, R; Soriano, V
      Intensification of antiretroviral therapy

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    21. Bossi, P; Tubiana, R; Calvez, V; Peytavin, G; Katlama, C; Bricaire, F
      Management of therapeutic escape in HIV-infected patients

      PRESSE MEDICALE
    22. Kirk, O; Mocroft, A; Pradier, C; Bruun, JN; Hemmer, R; Clotet, B; Miller, V; Viard, JP; Phillips, AN; Lundgren, JD
      Clinical outcome among HIV-infected patients starting saquinavir hard gel compared to ritonavir or indinavir

      AIDS
    23. Noor, MA; Lo, JC; Mulligan, K; Schwarz, JM; Halvorsen, RA; Schambelan, M; Grunfeld, C
      Metabolic effects of indinavir in healthy HIV-seronegative men

      AIDS
    24. Miller, V; Vandamme, AM; Loveday, C; Staszewski, S; Lundgren, J; Youle, M; Ait-Khaled, M; Boucher, C; Brun-Vezinet, F; Dedes, N; Giaquinto, C; Hertogs, K; Houyez, F; Perrin, L; Pillay, D; Schmit, JC; Schuurman, R; Lange, J; Banhegyi, D; Biondi, G; Broekhuizen, A; Bush-Donovan, C; Camacho, R; Carlier, H; Clavel, F; Clotet, B; Clumeck, N; Colebunders, R; De Clerq, K; De Jaegher, JJ; De Schrijver, G; De Smet, K; Hall, W; Harrigan, R; Hatzakis, A; Hellmann, N; Hoetelmans, R; Holtzer, C; Katlama, C; Larder, D; Loriaux, E; McCreedy, B; Mulcahy, F; Opravil, M; Phillips, A; Ruiz, N; Shulse, E; Sonnerborg, A; Soriano, V; Steel, H; Vella, S; Williams, A
      Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: recommendations for the European setting

      AIDS
    25. Gross, R; Bilker, WB; Friedman, HM; Strom, BL
      Effect of adherence to newly initiated antiretroviral therapy on plasma viral load

      AIDS
    26. Lepri, AC; Miller, V; Phillips, AN; Rabenau, H; Sabin, CA; Staszewski, S
      The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pre-therapy viral load and the weeks 4-8 viral load

      AIDS
    27. Deeks, SG; Martin, JN
      Reassessing the goal of antiretroviral therapy in the heavily pre-treated HIV-infected patient

      AIDS
    28. Podzamczer, D; Mallolas, J; Pena, JM; Pulido, F; Aguirrebengoa, K; Barros, C; Blazquez, R; Costa, JR; Dronda, F; Ena, J; Guerrero, A; Gutierrez, F; Juega, J; Labarga, P; Locutura, J; Aldeguer, JL; Moreno, S; Noguerado, A; Ocana, I; Padilla, B; Perez-Cecilia, E; Elias, MJP; Portilla, J; Rivero, A; Roca, V
      Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    29. McGrath, KM; Hoffman, NG; Resch, W; Nelson, JAE; Swanstrom, R
      Using HIV-1 sequence variability to explore virus biology

      VIRUS RESEARCH
    30. Manfredi, R; Chiodo, F
      Disorders of lipid metabolism in patients with HIV disease treated with antiretroviral agents: Frequency, relationship with administered drugs, and role of hypolipidaemic therapy with bezafibrate

      JOURNAL OF INFECTION
    31. Setti, M; Bruzzone, B; Ansaldi, F; Borrelli, P; Indiveri, F; Icardi, G
      Identification of key mutations in HIV reverse transcriptase gene can influence the clinical outcome of HAART

      JOURNAL OF MEDICAL VIROLOGY
    32. Blackwell, VC; Salis, P; Groves, RW; Baldeweg, SE; Conway, GS; Unwin, RJ
      Partial lipodystrophy, polycystic ovary syndrome and proteinuria: a commonlink to insulin resistance?

      JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
    33. Mantel-Teeuwisse, AK; Kloosterman, JME; Maitland-van der Zee, AH; Klungel, OH; Porsius, AJ; de Boer, A
      Drug-induced lipid changes - A review of the unintended effects of some commonly used drugs on serum lipid levels

      DRUG SAFETY
    34. Phillips, AN; Staszewski, S; Weber, R; Kirk, O; Francioli, P; Miller, V; Vernazza, P; Lundgren, JD; Ledergerber, B
      HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    35. Havlir, DV; Bassett, R; Levitan, D; Gilbert, P; Tebas, P; Collier, AC; Hirsch, MS; Ignacio, C; Condra, J; Gunthard, HF; Richman, DD; Wong, JK
      Prevalence and predictive value of intermittent viremia with combination HIV therapy

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    36. Staszewski, S; Keiser, P; Montaner, J; Raffi, F; Gathe, J; Brotas, V; Hicks, C; Hammer, SM; Cooper, D; Johnson, M; Tortell, S; Cutrell, A; Thorborn, D; Isaacs, R; Hetherington, S; Steel, H; Spreen, W
      Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    37. Erali, M; Page, S; Reimer, LG; Hillyard, DR
      Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods

      JOURNAL OF CLINICAL MICROBIOLOGY
    38. Servais, J; Lambert, C; Fontaine, E; Plesseria, JM; Robert, I; Arendt, V; Staub, T; Schneider, F; Hemmer, R; Burtonboy, G; Schmit, JC
      Comparison of DNA sequencing and a line probe assay for detection of humanimmunodeficiency virus type 1 drug resistance mutations in patients failing highly active antiretroviral therapy

      JOURNAL OF CLINICAL MICROBIOLOGY
    39. Richman, DD
      HIV chemotherapy

      NATURE
    40. Gonzalez-Castillo, J; Blanco, F; Soriano, V; Barreiro, P; Bravo, MC; Jimenez-Nacher, I; Gonzalez-Lahoz, J
      Opportunistic events shortly after beginning HAART in HIV-infected patients

      MEDICINA CLINICA
    41. Altfeld, MA; Livingston, B; Reshamwala, N; Nguyen, PT; Addo, MM; Shea, A; Newman, M; Fikes, J; Sidney, J; Wentworth, P; Chesnut, R; Eldridge, RL; Rosenberg, ES; Robbins, GK; Brander, C; Sax, PE; Boswell, S; Flynn, T; Buchbinder, S; Goulder, PJR; Walker, BD; Sette, A; Kalams, SA
      Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif

      JOURNAL OF VIROLOGY
    42. Call, SA; Saag, MS; Westfall, AO; Raper, JL; Pham, SV; Tolson, JM; Hellmann, NS; Cloud, GA; Johnson, VA
      Phenotypic drug susceptibility testing predicts long-term virologic suppression better than treatment history in patients with human immunodeficiencyvirus infection

      JOURNAL OF INFECTIOUS DISEASES
    43. Shugars, DC; Patton, LL; Freel, SA; Gray, LR; Vollmer, RT; Eron, JJ; Fiscus, SA
      Hyper-excretion of human immunodeficiency virus type 1 RNA in saliva

      JOURNAL OF DENTAL RESEARCH
    44. Nieuwkerk, PT; Sprangers, MAG; Burger, DM; Hoetelmans, RMW; Hugen, PWH; Danner, SA; van der Ende, ME; Schneider, MME; Schrey, G; Meenhorst, PL; Sprenger, HG; Kauffmann, RH; Jambroes, M; Chesney, MA; de Wolf, F; Lange, JMA
      Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort study

      ARCHIVES OF INTERNAL MEDICINE
    45. Demeter, LM; Hughes, MD; Coombs, RW; Jackson, JB; Grimes, JM; Bosch, RJ; Fiscus, SA; Spector, SA; Squires, KE; Fischl, MA; Hammer, SM
      Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine - AIDS clinical trials group protocol 320

      ANNALS OF INTERNAL MEDICINE
    46. Weinstein, MC; Goldie, SJ; Losina, E; Cohen, CJ; Baxter, JD; Zhang, H; Kimmel, AD; Freedberg, KA
      Use of genotypic resistance testing to guide HIV therapy: Clinical impact and cost-effectiveness

      ANNALS OF INTERNAL MEDICINE
    47. Turner, BJ; Hecht, FM
      Improving on a coin toss to predict patient adherence to medications

      ANNALS OF INTERNAL MEDICINE
    48. Moyle, G; Pozniak, A; Opravil, M; Clumeck, N; DelFraissy, JF; Johnson, M; Pelgrom, J; Reynes, J; Vittecoq, D; DeLora, P; Salgo, M; Duff, F
      The SPICE study: 48-week activity of combinations of saquinavir soft gelatin and nelfinavir with and without nucleoside analogues

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    49. Re, MC; Ramazzotti, E; Manfredi, R; Furlini, G; Vignoli, M; Maldini, C; Borderi, M; La Placa, M
      Viral load trend in HIV-1 seropositive patients with different CD4 cell counts before starting HAART

      JOURNAL OF CLINICAL VIROLOGY
    50. Wit, FWNM
      Experience with nevirapine in previously treated HIV-1-infected individuals

      ANTIVIRAL THERAPY
    51. Raffi, F; Reliquet, V; Ferre, V; Arvieux, C; Hascoet, C; Bellein, V; Besnier, JM; Breuz, JP; Garre, M; May, T; Molina, JM; Perre, P; Raguin, G; Rozenbaum, W; Zucman, D
      The VIRGO Study: nevirapine, didanosine and stavudine combination therapy in antiretroviral-naive HIV-1-infected adults

      ANTIVIRAL THERAPY
    52. Miller, V; Cozzi-Lepri, A; Hertogs, K; Gute, P; Larder, B; Bloor, S; Klauke, S; Rabenau, H; Phillips, A; Staszewski, S
      HIV drug susceptibility and treatment response to mega-HAART regimen in patients from the Frankfurt HIV cohort

      ANTIVIRAL THERAPY
    53. Clevenbergh, P; Durant, J; Halfon, P; del Giudice, P; Mondain, V; Montagne, N; Schapiro, JM; Boucher, CAB; Dellamonica, P
      Persisting long-term benefit of genotype-guided treatment for HIV-infectedpatients failing HAART. The Viradapt study: week 48 follow-up

      ANTIVIRAL THERAPY
    54. Powderly, WG
      Current approaches to treatment for HIV-1 infection

      JOURNAL OF NEUROVIROLOGY
    55. Nunez, M; Soriano, V
      Salvage therapy for HIV infection: When and how

      AIDS PATIENT CARE AND STDS
    56. Girard, PM; Guiguet, M; Bollens, D; Goderel, I; Meyohas, MC; Lecomte, I; Raguin, G; Frottier, J; Rozenbaum, W; Jaillon, P
      Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens

      CLINICAL INFECTIOUS DISEASES
    57. Harrigan, PR; Cote, HCF
      Clinical utility of testing human immunodeficiency virus for drug resistance

      CLINICAL INFECTIOUS DISEASES
    58. Deeks, SG
      Determinants of virological response to antiretroviral therapy: Implications for long-term strategies

      CLINICAL INFECTIOUS DISEASES
    59. Vigano, A; Saresella, M; Villa, ML; Ferrante, P; Clerici, M
      CD38+CD8+T cells as a marker of poor response to therapy in HIV-infected individuals

      HUMAN CD38 AND RELATED MOLECULES
    60. Deayton, JR; Griffiths, PD
      When can cytomegalovirus prophylaxis and maintenance therapy be stopped inHIV disease?

      CURRENT OPINION IN INFECTIOUS DISEASES
    61. Kartsonis, NA; D'Aquila, RT
      Clinical monitoring of HIV-1 infection in the era of antiretroviral resistance testing

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    62. Tantisiriwat, W; Powderly, WG
      Prophylaxis of opportunistic infections

      INFECTIOUS DISEASE CLINICS OF NORTH AMERICA
    63. Clevenbergh, P; Durant, J; Garraffo, R; Chaillou, S; Cua, E; Dellamonica, P
      Multiples aspects of VIH resistance to antiretroviral drugs.

      MEDECINE ET MALADIES INFECTIEUSES
    64. Carr, A; Chuah, J; Hudson, J; French, M; Hoy, J; Law, M; Sayer, D; Emery, S; Cooper, DA
      A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 study

      AIDS
    65. Angel, JB; High, K; Rhame, F; Brand, D; Whitmore, JB; Agosti, JM; Gilbert, MJ; Deresinski, S
      Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression

      AIDS
    66. Miller, V; Sabin, C; Hertogs, K; Bloor, S; Martinez-Picado, J; D'Aquila, R; Larder, B; Lutz, T; Gute, P; Weidmann, E; Rabenau, H; Phillips, A; Staszewski, S
      Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure

      AIDS
    67. Parkin, NT; Deeks, SG; Wrin, MT; Yap, J; Grant, RM; Lee, KH; Heeren, D; Hellmann, NS; Petropoulos, CJ
      Loss of antiretroviral drug susceptibility at low viral load during early virological failure in treatment-experienced patients

      AIDS
    68. Izopet, J; Massip, P; Souyris, C; Sandres, K; Puissant, B; Obadia, M; Pasquier, C; Bonnet, E; Marchou, B; Puel, J
      Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen

      AIDS
    69. Mocroft, A; Devereux, H; Kinloch-de-Loes, S; Wilson, D; Madge, S; Youle, M; Tyrer, M; Loveday, C; Phillips, AN; Johnson, MA
      Immunological, virological and clinical response to highly active antiretroviral therapy treatment regimens in a complete clinic population

      AIDS
    70. Falloon, J
      Salvage antiretroviral therapy

      AIDS
    71. Vergne, P; Bertin, P; Bonnet, C; Scotto, C; Treves, R
      Drug-induced rheumatic disorders - Incidence, prevention and management

      DRUG SAFETY
    72. Behrens, GMN; Stoll, M; Schmidt, RE
      Lipodystrophy syndrome in HIV infection - What is it, what causes it and how can it be managed?

      DRUG SAFETY
    73. Lederman, MM; Valdez, H
      Immune restoration with antiretroviral therapies - Implications for clinical management

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    74. Hertel, R
      The stiff shoulder

      ORTHOPADE
    75. Petropoulos, CJ; Parkin, NT; Limoli, KL; Lie, YS; Wrin, T; Huang, W; Tian, H; Smith, D; Winslow, GA; Capon, DJ; Whitcomb, JM
      A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    76. Abrams, EJ
      Opportunistic infections and other clinical manifestations of HIV disease in children

      PEDIATRIC CLINICS OF NORTH AMERICA
    77. Gulick, RM; Hu, XJ; Fiscus, SA; Fletcher, CV; Haubrich, R; Cheng, HL; Acosta, E; Lagakos, SW; Swanstrom, R; Freimuth, W; Snyder, S; Mills, C; Fischl, M; Pettinelli, C; Katzenstein, D
      Randomized study of saquinavir with ritonavir or nelfinavir together with delavirdine, adefovir, or both in human immunodeficiency virus-infected adults with virologic failure on indinavir: AIDS Clinical Trials Group study 359

      JOURNAL OF INFECTIOUS DISEASES
    78. Ledru, E; Christeff, N; Patey, O; de Truchis, P; Melchior, JC; Gougeon, ML
      Alteration of tumor necrosis factor-alpha T-cell homeostasis following potent antiretroviral therapy: contribution to the development of human immunodeficiency virus-associated lipodystrophy syndrome

      BLOOD
    79. Paredes, R; Mocroft, A; Kirk, O; Lazzarin, A; Barton, SE; van Lunzen, J; Katzenstein, TL; Antunes, F; Lundgren, JD; Clotet, B
      Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe - Results fromthe EuroSIDA Study

      ARCHIVES OF INTERNAL MEDICINE
    80. DeSimone, JA; Pomerantz, RJ; Babinchak, TJ
      Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy

      ANNALS OF INTERNAL MEDICINE
    81. Crook, MA; Mir, N
      Abnormal lipids and the acquired immunodeficiency syndrome: is there a problem and what should we do about it?

      INTERNATIONAL JOURNAL OF STD & AIDS
    82. Chen, A; Zaidi, AKM; Mueller, BU; Huskins, WC; Perez-Atayde, AR; McIntosh, K
      Pneumocystis carinii presenting as a mediastinal mass in a child with acquired immunodeficiency syndrome

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    83. Paris, D; Ledergerber, B; Weber, R; Jost, J; Flepp, M; Opravil, M; Ruef, C; Zimmerli, S
      Incidence and predictors of virologic failure of antiretroviral triple-drug therapy in a community-based cohort

      AIDS RESEARCH AND HUMAN RETROVIRUSES
    84. Shafer, RW; Vuitton, DA
      Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1

      BIOMEDICINE & PHARMACOTHERAPY
    85. Carosi, G; Torti, C; Palvarini, L; Roldan, EQ
      HIV-1 pharmacoresistance: clinical and therapeutic implications

      JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS
    86. Essajee, SM; Kim, M; Gonzalez, C; Rigaud, M; Kaul, A; Chandwani, S; Hoover, W; Lawrence, R; Spiegel, H; Pollack, H; Krasinski, K; Borkowsky, W
      Immunologic and virologic responses to HAART in severely immunocompromisedHIV-1-infected children

      AIDS
    87. Fatkenheuer, G; Hoetelmans, RMW; Hunn, N; Schwenk, A; Franzen, C; Reiser, M; Jutte, A; Rockstroh, J; Diehl, V; Salzberger, B
      Salvage therapy with regimens containing ritonavir and saquinavir in extensively pretreated HIV-infected patients

      AIDS
    88. Gea-Banacloche, JC; Lane, HC
      Immune reconstitution in HIV infection

      AIDS
    89. Hirschel, B; Opravil, M
      The year in review: antiretroviral treatment

      AIDS
    90. Roca, B; Gomez, CJ; Arnedo, A
      Stavudine, lamivudine and indinavir in drug abusing and non-drug abusing HIV-infected patients: Adherence, side effects and efficacy

      JOURNAL OF INFECTION
    91. Pradier, C; Pesce, A; Carrieri, P; Cottalorda, J; Boyer, P; Senesi, C; Fuzibet, JG; Dellamonica, P; Cassuto, JP
      Effect of indinavir and higher CD4+T-cell count on viral load response after 6 months of highly active antiretroviral therapy

      CLINICAL THERAPEUTICS
    92. Jensen-Fangel, S; Kirk, O; Larsen, L; Blaxhult, A; Gerstoft, J; Pedersen, C; Black, FT; Lundgren, JD; Obel, N
      Saquinavir hard gel suppresses viral load insufficiently in HIV-infected patients naive to anti-retroviral therapy: A retrospective cohort study

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    93. Blanche, P; Passeron, A; Gombert, B; Ginsburg, C; Salmon, D; Sicard, D
      Sarcoidosis and HIV infection: Influence of highly active antiretroviral therapy

      BRITISH JOURNAL OF DERMATOLOGY
    94. VIRABEN R; AQUILINA C
      INDINAVIR-ASSOCIATED LIPODYSTROPHY

      AIDS
    95. BARDONNET K; GIL H; LEBRUN C; DEWAZIERES B; DUPOND JL
      DIABETES-MELLITUS ASSOCIATED WITH PROTEASE INHIBITORS THERAPY IN HIV-INFECTED PATIENTS

      La Revue de medecine interne
    96. Blanche, P; Gombert, B; Ginsburg, C; Passeron, A; Stubei, I; Rigolet, A; Salmon, D; Sicard, D
      HIV combination therapy: Immune restitution causing cryptococcal lymphadenitis dramatically improved by anti-inflammatory therapy

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES

    97. ANTIRETROVIRAL THERAPY AND MEDICAL-MANAGEMENT OF PEDIATRIC HIV-INFECTION

      Pediatrics (Evanston)


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 07:42:05